We are live on ! Find out more
NGNE icon

Neurogene
NGNE

25 hedge funds and large institutions have $34.1M invested in Neurogene in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 22 → 25 (+3)

9% more capital invested

Capital invested by funds: $31.2M → $34.1M (+$2.91M)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
9
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$254K
2
UBS Group
UBS Group
Switzerland
+$190K
3
SIM
Spark Investment Management
New York
+$43.7K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$39.6K
5
BA
BlackRock Advisors
Delaware
+$16.3K

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$446K
2
Deutsche Bank
Deutsche Bank
Germany
-$306K
3
BBA
Baker Bros. Advisors
New York
-$231K
4
CAM
Cormorant Asset Management
Massachusetts
-$204K
5
RA
Royce & Associates
New York
-$179K

NGNE Hedge Fund Activity: Q1 2015 in Review

25 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2015, worth a combined $34.1M — up 9.3% from $31.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NGNE positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $254K. The largest seller was Driehaus Capital Management, cutting an estimated $446K.

  • 25 institutional investors held Neurogene (NGNE) as of Q1 2015, up from 22 in Q4 2014.
  • Funds reported $34.1M of Neurogene stock for Q1 2015, up 9.3% quarter-over-quarter.
  • 3 funds opened new Neurogene positions in Q1 2015 and 0 closed out, a net change of +3 holders.
  • The largest Neurogene buyer in Q1 2015 was Visium Asset Management, an estimated $254K added.
  • The largest Neurogene seller in Q1 2015 was Driehaus Capital Management, an estimated $446K sold.

Based on aggregated 13F filings for Q1 2015.